Drug intelligence / Profile preview

68Ga-A9-0922

Development stage
Preclinical
Lead developer
Alpha-9 Oncology
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

68Ga-A9-0922 is a diagnostic radiopharmaceutical developed by Alpha-9 Oncology for the imaging of solid tumors, specifically pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer. It consists of a ligand (A9-0922) targeting **integrin alpha-v beta-6 (αvβ6)**, which is chelated with the positron-emitting radioisotope **Gallium-68 (68Ga)** for use in Positron Emission Tomography (PET). Integrin αvβ6 is a cell surface receptor that is significantly upregulated in various epithelial cancers and is associated with tumor progression and poor prognosis, while remaining largely absent in healthy adult tissues. The agent is currently in IND-enabling studies as part of a theranostic pair, intended to identify patients suitable for targeted radioligand therapy.

Other names
[68Ga]Ga-A9-0922
02

Targets

αVβ6 (Integrin αVβ6)

Beyond the preview

Go deeper on 68Ga-A9-0922.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-A9-0922.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call